[Drug therapy of dyslipidemias].
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001647:Bile Acids and Salts / Q000378:metabolism; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D007408:Intestinal Absorption / Q000187:drug effects; D050356:Lipid Metabolism; D011736:Pyridoxine / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D001647:Bile Acids and Salts; D000960:Hypolipidemic Agents; D002792:Cholestyramine Resin; D006493:Heparin; D002994:Clofibrate; D011736:Pyridoxine
Terapia farmacologica delle dislipidemie